S-1: Capstone Holding Corp. Files S-1 for Resale of 5.19 Million Shares by Tumim Stone Capital, Securing Up to $20M in Equity Financing

Sentiment:

Registration Statement 3 June 2025 4:11 PM

Capstone Holding Corp. has filed an S-1 registration statement for the resale of up to 5,190,251 shares of common stock by Tumim Stone Capital, LLC, stemming from a new equity line of credit that could provide the company with up to $20 million in gross proceeds for working capital and general corporate purposes.

Capital raiseThe company has entered into a Common Stock Purchase Agreement with Tumim Stone Capital, LLC, granting it the right, but not the obligation, to sell up to $20.0 million in aggregate gross purchase price of its Common Stock.The shares will be sold at a purchase price equal to 97% of the lowest daily volume-weighted average price (VWAP) of the Common Stock on the Nasdaq Capital Market during the three consecutive trading days immediately following a purchase notice.As consideration for Tumim Stone Capital's commitment, the company is obligated to issue 215,054 Commitment Shares.The issuance of shares is subject to an 'Exchange Cap' of 1,038,050 shares (19.99% of shares outstanding prior to the agreement), unless stockholder approval is obtained or the average per share purchase price equals or exceeds $1.77.Tumim Stone Capital's beneficial ownership is capped at 4.99% of outstanding shares, unless it elects to increase this limit to 9.99%.Joseph Gunnar & Co., LLC, as the placement agent, will receive a cash fee equal to 7.0% of the gross proceeds from each drawdown under the equity line, plus reimbursement of up to $15,000 for expenses.The company has also agreed to reimburse Tumim Stone Capital for its counsel fees up to $80,000.

Summary

Capstone Holding Corp. (CAPS) is a building products distribution network, primarily through its subsidiary Instone, which is the largest wholesale distributor in the thin veneer masonry products industry.
This S-1 filing registers 5,190,251 shares of common stock for resale by Tumim Stone Capital, LLC, comprising 215,054 Commitment Shares and 4,975,197 Equity Line Securities, issued under a Common Stock Purchase Agreement dated May 14, 2025.
The company will not receive any proceeds from the resale of these shares by Tumim Stone Capital; however, Capstone may receive up to $20.0 million in aggregate gross proceeds from sales of its common stock directly to Tumim Stone Capital over approximately 24 months, at Capstone's discretion.
Proceeds from these direct sales to Tumim Stone Capital are intended for working capital and general corporate purposes, including the repayment of outstanding indebtedness.
Capstone's common stock is listed on the Nasdaq Capital Market under the symbol CAPS, with a closing sale price of $1.82 per share on May 30, 2025.
The company is classified as a 'controlled company' due to entities controlled by its CEO and Chairman owning over 50% of voting stock, though it does not intend to rely on associated corporate governance exemptions.
Instone's revenues increased from approximately $32.2 million in April 2020 to approximately $44.9 million by December 31, 2024.
Capstone completed a follow-on public offering of 1,250,000 shares on March 7, 2025, and uplisted to Nasdaq on March 6, 2025.
As of March 31, 2025, the company had a historical net tangible book value (deficit) of $(6,952,292), or $(1.34) per share; after giving effect to the issuance of 5,190,251 shares at $1.82 per share, the as-adjusted net tangible book value (deficit) would be approximately $(7,083,792), or $(0.68) per share, resulting in an immediate dilution of $(2.50) per share to new investors.

Sentiment

Score: 7

Explanation: The document outlines a clear growth strategy, highlights successful past acquisitions, and secures a significant equity line of credit, indicating positive future potential for expansion and operational stability. However, the substantial potential for dilution to existing shareholders and the company's current net tangible book deficit temper the overall positive sentiment, suggesting a 'hold' rather than a 'strong buy' recommendation.

Positives

Secured an equity line of credit for up to $20.0 million with Tumim Stone Capital, providing a potential source of capital for working capital and general corporate purposes.
Successfully uplisted its common stock to the Nasdaq Capital Market (CAPS) on March 6, 2025, enhancing market visibility and liquidity.
Completed a follow-on public offering of 1,250,000 shares of Common Stock on March 7, 2025.
Instone, the primary operating subsidiary, demonstrated revenue growth from approximately $32.2 million in April 2020 to $44.9 million by December 31, 2024.
Benefits from a deep team with significant industry expertise, including Brookstone Partners' 25 years in building products investment and a Lead Independent Director with 19 years at Owens Corning.
Proven track record of successful acquisitions and integrations, having integrated four acquisitions since 2006.
Strategically positioned to capitalize on M&A opportunities in the building products sector, particularly during periods of interest rate peaks, aligning with positive industry trends noted in the Bain & Company Global M&A Report.
Expanded market presence by onboarding customers in 6 new states in 2024, extending its distribution network to 31 states.
Introduced the 'Toro' family of manufactured stone products, which is expected to drive significant organic revenue growth in the next three years.

Negatives

The company will not receive any proceeds from the resale of shares by the selling stockholder, Tumim Stone Capital, LLC.
The issuance of shares under the Purchase Agreement will have a dilutive impact on existing stockholders, with an immediate dilution of $(2.50) per share to new investors.
The company's net tangible book value is a deficit, and the offering will further increase the deficit per share for new investors.
The actual gross proceeds from the $20.0 million commitment may be substantially less than the full amount, depending on market prices and limitations imposed by the Nasdaq Exchange Cap.
Even if the company receives the full $20.0 million from the equity line, it may still require additional capital to fully implement its business, operating, and development plans.

Risks

It is not possible to predict the actual number of shares the company will sell under the Purchase Agreement or the actual gross proceeds, which could be substantially less than the $20.0 million total commitment.
The company may not have access to the full amount available under the Purchase Agreement, which could materially adversely affect its liquidity and ability to satisfy working capital needs.
Future sales of a substantial amount of common stock by the selling stockholder, or the perception of such sales, could depress the market price of the company's common stock.
Investors may experience future dilution as a result of the issuance of shares under the Purchase Agreement, future equity offerings, and other issuances of common stock or other securities.
Management will have broad discretion over the use of proceeds from sales to the selling stockholder, and such uses may not necessarily improve the company's financial condition or market value.
The company's status as a 'controlled company' could potentially allow it to rely on exemptions from certain corporate governance requirements, although it currently states it does not intend to.
As an emerging growth company and smaller reporting company, the company may take advantage of scaled disclosure, which some investors may find less attractive, potentially impacting trading market activity and stock price volatility.

Future Outlook

Capstone Holding Corp.'s long-term growth strategy is centered on expanding its building products distribution network through both organic growth and strategic acquisitions. The company aims to enhance its product portfolio by introducing new materials and expanding into adjacent building products, optimize operations for efficiency and cost reduction, and maintain a customer-centric approach. Innovation, exemplified by the new 'Toro' manufactured stone products, is expected to drive significant organic revenue growth in the next three years. The company believes it is strategically positioned to leverage current market conditions and M&A opportunities within the building products sector, particularly during periods of interest rate peaks, to scale its EBITDA and enhance shareholder value.

Management Comments

"Capstone is controlled by Brookstone Partners, a private equity group with 25 years of deep expertise in building products investment."
"The Capstone leadership team includes seasoned operating executives and building products acquisition and investment professionals."
"We believe we are strategically positioned to capitalize on market conditions within the building products sector. Historically, acquiring companies at interest rate peaks has yielded strong returns, and we are poised to leverage these strategic investment opportunities as the market evolves."
"We believe we are strategically well-positioned to take advantage of the current market opportunities because of: Team strength. Experience integrating acquisitions. Geographic distribution footprint of Instone."
"As Capstone continues to scale, growing its EBITDA, we anticipate benefiting from valuation premiums associated with increased size. This growth, coupled with consistent earnings performance, is expected to drive substantial shareholder value and enhance our market positioning."
"We expect Toro to help drive significant organic revenue growth in the next three years."
"We do not anticipate paying dividends on our Common Stock for the foreseeable future."

Industry Context

The document highlights that the building products sector is ripe for M&A, citing the Bain & Company Global M&A Report (2024). This report suggests that companies willing to make 'bold moves' and frequent, material acquisitions significantly outperform inactive companies in total shareholder returns (9.6% vs. 2.7%). The report also indicates an improving M&A environment due to opportunities to acquire struggling assets and reduced competition from financial investors. Capstone's strategy of pursuing both scale and scope M&A, leveraging its experienced team and existing distribution network, aligns with these industry trends and aims to capitalize on the current market dynamics.

Comparison to Industry Standards

Capstone's strategy of pursuing frequent and material acquisitions aligns with findings from the Bain & Company Global M&A Report, which indicates that building products companies engaging in such M&A substantially outpace inactive companies in total shareholder returns (9.6% vs. 2.7%).
The presence of Charles Dana, Lead Independent Director, who spent 19 years at Owens Corning (a leading building materials company), provides Capstone with a level of industry expertise and strategic insight comparable to established industry leaders.
Brookstone Partners' successful track record, including an $8.8 million investment in Woodcrafters Home Products Holdings LLC that yielded $32 million upon sale, demonstrates a capability in identifying and growing assets within the building products sector that is indicative of strong investment performance within the industry.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Controlled Company Status	Capstone is a 'controlled company' as defined under Nasdaq Stock Market Rules, due to entities controlled by Matthew Lipman (CEO) and Michael Toporek (Chairman) owning over 50% of the company's voting stock. However, the company states it does not intend to rely on the exemptions to corporate governance requirements available to controlled companies.	May 30, 2025	While the company states it will not rely on exemptions, the controlled status indicates concentrated voting power, which could influence corporate decisions. The decision not to rely on exemptions is positive for minority shareholder rights.
Emerging Growth and Smaller Reporting Company Status	The company is an 'emerging growth company' and a 'smaller reporting company,' allowing it to take advantage of certain scaled disclosure requirements. It has elected not to use the extended transition period for complying with new or revised financial accounting standards.	Ongoing	Scaled disclosure may result in less information for investors compared to larger public companies, potentially affecting market attractiveness. The decision to forgo the extended accounting transition period indicates a commitment to public company accounting standards sooner.
Authorized Share Capital Increase	On February 20, 2025, the company increased its authorized shares of Common Stock to 50,000,000 and preferred stock to 25,000,000.	February 20, 2025	This increase provides the company with greater flexibility for future equity financings, acquisitions, or other corporate purposes, but also enables significant potential dilution.
Series B Preferred Stock Designation	On February 20, 2025, the company designated 2 million shares of its authorized preferred stock as Series B Preferred Stock.	February 20, 2025	This creates a new class of preferred stock that can be used for financing or other strategic purposes, potentially with different rights and preferences than common stock.
Tax Benefit Preservation Plan Cancellation	A Tax Benefit Preservation Plan (poison pill) adopted on May 1, 2024, to protect Net Operating Losses (NOLs) was cancelled.	March 3, 2025	The cancellation removes a potential anti-takeover defense mechanism, which could make the company more vulnerable to hostile takeovers but also potentially more attractive to investors seeking less restrictive governance.

Related Party Transactions

Brookstone Partners, controlled by CEO Matthew Lipman and Chairman Michael Toporek, has deep involvement and control over Capstone Holding Corp.
BP Peptides, LLC, a Brookstone entity, has been a significant lender and shareholder, converting substantial amounts of secured debt and accrued interest into Common Stock (e.g., $572,700 in Dec 2020 and $2,639,364 in March 2022).
Brookstone Acquisition Partners XXI, LLC, a related entity to the company's majority shareholder, provided an $800,000 unsecured promissory note to Capstone.
Nectarine Management LLC, an entity controlled by Michael Toporek, purchased 985,063 shares of Series B Preferred Stock for $30,000 on February 25, 2025.
A management agreement between TotalStone and Capstone Holding Corp. was in effect until its termination on April 1, 2025.

Stakeholder Impact

**Shareholders**: Existing shareholders face significant potential dilution from the issuance of new shares under the equity line of credit. While the offering may provide necessary capital, the immediate dilution to new investors is substantial, and future sales by the selling stockholder could depress the share price.
**Customers**: The company's strategic pillars, including expanding market presence, enhancing product portfolio, and focusing on operational excellence and innovation (e.g., Toro products), are aimed at providing superior value and service to customers.
**Creditors**: The potential use of proceeds from the equity line for the repayment of outstanding indebtedness could benefit creditors by improving the company's debt servicing capacity.

Next Steps

The company will file further amendments to the Registration Statement as necessary to delay its effective date until specifically stated or determined by the SEC.
The company may elect to sell shares to Tumim Stone Capital under the Purchase Agreement over an approximately 24-month period, subject to market conditions and other factors.
If the company needs to sell more than the currently registered 4,975,197 shares to reach the $20.0 million commitment, it must file additional registration statements with the SEC.
The company may need to obtain stockholder approval to issue shares in excess of the Nasdaq Exchange Cap (19.99% of pre-agreement outstanding shares) unless the average purchase price is $1.77 or higher.
Capstone plans to continue executing its strategic pillars: expanding market presence, enhancing its product portfolio, optimizing operational excellence, maintaining a customer-centric approach, and driving innovation.

Key Dates

Date	Description
1987	Company formed as OrthoLogic Corp.
2005	Company filed its restated certificate of incorporation.
October 4, 2006	TotalStone, LLC formed.
February 2008	Brookstone Partners affiliate invested $8.8 million in Woodcrafters Home Products Holdings LLC.
2010	Company changed its name to Capstone Therapeutics Corp.
December 2013	Brookstone completed the sale of all its interests in Woodcrafters for $32 million.
June 22, 2015	Amended and Restated Certificate of Designation of Series A Preferred Stock.
August 25, 2016	Series B Preferred Stock and Warrant Purchase Agreement.
July 14, 2017	Company entered into a Securities Purchase, Loan and Security Agreement with BP Peptides, LLC (Brookstone), funding $3.44 million.
August 11, 2017	Series B-2 Preferred Stock Purchase Agreement.
December 20, 2017	Revolving Credit, Term Loan and Security Agreement with Berkshire Bank.
January 30, 2018	First Amendment to Securities Purchase Loan and Security Agreement.
February 1, 2018	Warrant to Purchase Common Stock issued to BP Peptides, LLC.
March 15, 2019	Second Amendment to Securities Purchase Loan and Security Agreement.
August 22, 2019	Company filed a certificate of amendment for a 1-for-1,000 reverse stock split.
August 23, 2019	LipimetiX Development, Inc. Contingent Value Rights Agreement.
November 14, 2019	NEM Purchaser, LLC completed the purchase of Northeast Masonry Distributors, LLC for $6,029,342.
March 2020	Company and Brookstone amended the Brookstone Agreement to extend the Secured Debt's maturity to March 31, 2022.
March 27, 2020	Third Amendment to Securities Purchase Loan and Security Agreement and Management Fee Agreement with Capstone Holding Corp.
April 1, 2020	Company obtained a 100% interest in TotalStone.
December 2020	Brookstone converted $572,700 of accrued interest and secured debt into 24,900 shares of Capstone Common Stock.
March 15, 2021	Fourth Amendment to Securities Purchase Loan and Security Agreement.
March 31, 2021	Limited Payment Guarantee between Capstone Therapeutics Corp. and Brookstone Acquisition Partners XXI Corporation.
November 26, 2021	Fourth Amended and Restated Operating Agreement of TotalStone, LLC became effective.
November 22, 2021	Term Note Issued by TotalStone, LLC to Berkshire Bank.
February 2022	Company legally changed its name from Capstone Therapeutics Corp. to Capstone Holding Corp.
March 2022	Brookstone converted $688,104 of accrued interest and $1,951,260 of secured debt into 78,153 shares of Capstone Common Stock.
June 15, 2022	Brookstone converted $1.9 million of accrued interest and secured debt into 78,333 shares of the Company's Common Stock.
March 8, 2023	Second Amended and Restated Credit Agreement with Stream Finance, LLC.
November 2023	Capstone and Brookstone Acquisition Partners XXI, LLC agreed to terms of an unsecured promissory note for $800,000.
March 31, 2024	$800,000 unsecured promissory note formalized and issued.
May 1, 2024	Board authorized a dividend distribution of one right for each outstanding share of Common Stock (Tax Benefit Preservation Plan).
October 18, 2024	Consent, Waiver and Amendment to Second Amended and Restated Credit Agreement.
November 11, 2024	BP Peptides, LLC and the Company agreed to the Second Amended and Restated Note, extending maturity to June 30, 2026.
November 15, 2024	Amendment of Amended and Restated Management Fee and Transaction Fee Agreement.
December 31, 2024	Instone's revenues reached approximately $44.9 million.
February 20, 2025	Company filed an amendment to its Restated Certificate of Incorporation to increase authorized shares of Common Stock to 50,000,000 and preferred stock to 25,000,000. Also filed Certificate of Designation for 2 million shares of Series B Preferred Stock.
February 25, 2025	Company entered into a subscription agreement with Nectarine Management LLC for the sale of 985,063 shares of Series B Preferred Stock for $30,000.
March 3, 2025	The Tax Benefit Preservation Plan was cancelled per the Master Exchange and Other Transaction Agreement.
March 6, 2025	Company's Common Stock began trading on the Nasdaq Capital Market under the symbol CAPS. Series B Preferred Stock was issued.
March 7, 2025	Company closed its follow-on public offering of 1,250,000 shares of Common Stock. A restructuring was completed, making the Company the sole member of TotalStone.
March 31, 2025	Historical net tangible book value (deficit) was $(6,952,292).
April 1, 2025	The management agreement between TotalStone and the Company was terminated.
May 14, 2025	Company entered into the Purchase Agreement and a Registration Rights Agreement with Tumim Stone Capital, LLC.
May 15, 2025	Placement Agency Agreement with Joseph Gunnar & Co., LLC.
May 30, 2025	Closing sale price of Common Stock was $1.82 per share.
June 3, 2025	Filing date of the S-1 Registration Statement.
June 30, 2026	Maturity date for the Second Amended and Restated Note with BP Peptides, LLC and the $800,000 unsecured promissory note.

Recommendation

hold

Keywords

Capstone Holding Corp., CAPS, SEC S-1, Registration Statement, Equity Line of Credit, Tumim Stone Capital, Common Stock, Resale Offering, Building Products Distribution, Instone, Thin Veneer Stone, Masonry Products, Nasdaq Capital Market, Dilution, Corporate Governance, Emerging Growth Company, Smaller Reporting Company, Brookstone Partners, Capital Raise, Working Capital

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.